viewOxySure Systems

Oxysure doubles production due to order backlog

It comes as the company signed a deal last week with Essendant (NASDAQ:ESND)

The company makes emergency oxygen kits

Emergency oxygen kit provider OxySure Therapeutics (OTCQB: OXYS) has doubled its production capacity as demand ramps up for its products.

It comes as the company, which produces a range of easy-to-use emergency oxygen products with its "oxygen from powder" technology, signed a deal last week with Essendant (NASDAQ:ESND), a global distributor of workplace essentials with $5.4 billion in sales, subsidiary ORS Nasco.

Richard Bryant, OxySure's production manager, said: “Through recent investments in infrastructure and additional manufacturing staff we were able to reduce our current backlog from two months to one month.

“We plan to further add additional production capacity by adding some anticipated process changes, as well as further acquisitions of equipment and additional manufacturing staff.”

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


FansUnite Entertainment pleased Canada taking a look at allowing single...

FansUnite Entertainment (CSE: FANS- OTCQB: FUNFF) President Darius Eghdami joined Steve Darling from Proactive with news the company is hailing the Canadian government’s decision to introduce legislation that would legalize single-event sports betting in Canada. Eghdami talks about why that...

2 days, 6 hours ago

2 min read